How many acquisitions has Amgen made so far?

Amgen has completed 27 acquisitions so far, with an average acquisition amount of $4.26B.

Which countries does Amgen usually acquire in?

Amgen has made acquisitions in 9 countries with the most activity in United States and Japan.

Which is Amgen's latest acquisition?

Amgen's most recent acquisition is Dark Blue Therapeutics, a Biotechnology company focused on drugs discovery services, acquired in January 2026.

Which sectors does Amgen target for acquisitions?

Most of Amgen's acquisitions are in Diversified Pharmaceuticals (6) and Immunotherapy (6).

In which year did Amgen make the most acquisitions?

Amgen was most active in 2012, with 5 acquisitions completed in that year.

List of 27 Acquisitions by Amgen (Oct 2026)

Most viewed in 2019

Amgen has made a total of 27 acquisitions. Its activity spans 17 sectors, including Oncology, Diversified Pharmaceuticals, and Immunotherapy, across nine countries, such as United States, Japan, and United Kingdom. Peak acquisition years were 2012 with 5 acquisitions, 2021 with 3 acquisitions, and 2022 with 2 acquisitions. The average number of acquisitions per year from 2020 to 2025 is 1, and the company has completed 1 acquisition so far this year. Its most recent acquisition is Dark Blue Therapeutics, an Oxford-based biotechnology company focused on drug discovery services that was founded in 2020 and acquired in January 2026.

Here's the year on year acquisition history of Amgen:

Number of Total Acquisitions

Year	# Acquisitions
2026	1
2022	2
2021	3
2020	1
2019	2
2017	2
2015	1
2013	1
2012	5
2011	1
2007	2
2006	1
2005	1
2004	1
2001	1
2000	1
1994	1

View all Acquisitions by Amgen

Recent acquisitions by Amgen

Amgen's most recent acquisition - Dark Blue Therapeutics is a Biotechnology company focused on drugs discovery services, founded in 2020 and located in Oxford. Amgen acquired it in January 2026 for a price of $*****.

Here is the list of all acquisitions by Amgen sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Jan 06, 2026	Dark Blue Therapeutics	nmwu	nsgn	31	785
Dec 12, 2022	Horizon Therapeutics	jges	koly	34	493
Aug 04, 2022	ChemoCentryx	tzzv	teqa	64	166
Jul 27, 2021	TeneoBio	{foe	iijg	76	328
Mar 30, 2021	Rodeo Therapeutics	mckl	isnz	91	113